English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Vivanza Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Vivanza Biosciences

    Small Cap
    ₹3.8
    -0.03 (-0.78%)
    30 September, 2024 03:33 BSE: 530057 NSE: VIVANZAISIN: INE984E01035
    Split

    Start SIP in Vivanza Biosciences

    Start SIP

    Vivanza Biosciences Performance

    Day Range

    • Low 0
    • High 0
    ₹ 3

    52 Week Range

    • Low 0
    • High 0
    ₹ 3
    • Open Price0
    • Previous Close0
    • Volume

    Vivanza Biosciences Share Price

    • Over 1 Month -11.83%
    • Over 3 Month -26.07%
    • Over 6 Month -44.04%
    • Over 1 Year -65.3%

    Vivanza Biosciences Key Statistics

    Vivanza Biosciences Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 023456
    Operating Expenses Qtr Cr 023446
    Operating Profit Qtr Cr 000000
    Depreciation Qtr Cr 000000
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 000000
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1415
    Operating Expenses Annual Cr 1413
    Operating Profit Annual in Cr 11
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 01
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 20
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr -20
    Net Cash Flow Annual Cr 00
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 54
    Fixed Assets Annual Cr 00
    Total Non Current Assets Annual Cr 33
    Total Current Assets Annual Cr 1418
    Total Assets Annual Cr 1720
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 11
    ROE Annual % 713
    ROCE Annual % 1525
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 68
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 247898
    Operating Expenses Qtr Cr 256798
    Operating Profit Qtr Cr 000010
    Depreciation Qtr Cr 000000
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 000000
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2818
    Operating Expenses Annual Cr 2717
    Operating Profit Annual in Cr 11
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 11
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 2-1
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr -21
    Net Cash Flow Annual Cr 00
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 54
    Fixed Assets Annual Cr 11
    Total Non Current Assets Annual Cr 43
    Total Current Assets Annual Cr 1620
    Total Assets Annual Cr 2022
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 11
    ROE Annual % 1215
    ROCE Annual % 1521
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 46
    Invest in Vivanza Biosciences

    Vivanza Biosciences Technicals

    EMA & SMA

    Current Price
    ₹3.8
    -0.03 (-0.78%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹3.96
    • 50 Day
    • ₹4.35
    • 100 Day
    • ₹5.14
    • 200 Day
    • ₹6.60
    • 20 Day
    • ₹3.93
    • 50 Day
    • ₹4.28
    • 100 Day
    • ₹5.14
    • 200 Day
    • ₹6.79

    Vivanza Biosciences Resistance and Support

    PIVOT
    ₹3.79
    Resistance
    First Resistance 3.81
    Second Resistance 3.83
    Third Resistance 3.85
    RSI 33.40
    MFI 29.03
    MACD Single Line -0.15
    MACD -0.14
    Support
    First Support 3.77
    Second Support 3.75
    Third Supoort 3.73

    Vivanza Biosciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 72,676 7,267,600 100
    Week 58,088 5,808,840 100
    1 Month 49,499 4,949,886 100
    6 Month 300,528 26,620,782 88.58

    Vivanza Biosciences Result Highlights

    Vivanza Biosciences Synopsis

    BSE-Medical-Diversified

    Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.41 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2024. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.
    Market Cap 15
    Sales 10
    Shares in Float 2.40
    No of funds 2
    Yield
    Book Value 3.22
    U/D Vol ratio 0.7
    LTDebt / Equity 16
    Alpha -0.6
    Beta 0.24

    Vivanza Biosciences Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 40.05%43.24%44.9%47.29%
    Financial Institutions/ Banks
    Individual Investors 45.01%13.82%9.05%6.23%
    Others 14.94%42.94%46.05%46.48%

    Vivanza Biosciences Management

    Name Designation
    Mr. J A Mehta Managing Director
    Mr. H A Parikh Director
    Ms. Rina Kumari Director
    Mr. A P Shah Director

    Vivanza Biosciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Vivanza Biosciences Corporate Action

    Date Purpose Remarks
    2024-08-08 Quarterly Results
    2024-07-05 Others Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; split from Rs. 10/- to Re. 1/-.
    2024-04-30 Audited Results
    2024-02-06 Quarterly Results
    2023-10-26 Quarterly Results
    Date Purpose Remarks
    2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

    Vivanza Biosciences MF Shareholding

    Name Amount(cr)

    Vivanza Biosciences FAQs

    What is Share Price of Vivanza Biosciences ?

    Vivanza Biosciences share price is ₹3 As on 30 September, 2024 | 03:19

    What is the Market Cap of Vivanza Biosciences ?

    The Market Cap of Vivanza Biosciences is ₹15.2 Cr As on 30 September, 2024 | 03:19

    What is the P/E ratio of Vivanza Biosciences ?

    The P/E ratio of Vivanza Biosciences is 47.6 As on 30 September, 2024 | 03:19

    What is the PB ratio of Vivanza Biosciences ?

    The PB ratio of Vivanza Biosciences is 3.3 As on 30 September, 2024 | 03:19

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.